|
Re: Just back from IR,...
|
2
|
Resverlogix Corp.
|
Oct 27, 2019 11:15AM
|
|
Re: Resverlogix Closes Extension of Maturity Date of Loan and Announces Private Placement
|
2
|
Resverlogix Corp.
|
Sep 07, 2017 09:19AM
|
|
Re: Zenith funding???
|
2
|
Zenith Epigenetics
|
Jun 24, 2019 01:48PM
|
|
Re: Entertainment During Wait
|
2
|
Resverlogix Corp.
|
Aug 25, 2017 03:24PM
|
|
Re: 002399:CH
|
2
|
Resverlogix Corp.
|
Jul 11, 2017 03:23PM
|
|
Re: Insiders info
|
2
|
Resverlogix Corp.
|
Aug 09, 2015 01:10PM
|
|
Rambling thoughts re 2017 and the future
|
2
|
Resverlogix Corp.
|
Jan 04, 2018 04:05PM
|
|
Re: Resverlogix Announces FDA Confirmation Regarding Filing Pathway for Apabetalone
|
2
|
Resverlogix Corp.
|
Jun 15, 2018 02:20PM
|
|
Re: ZEN-3694 mCRPC Trial Status
|
2
|
Zenith Epigenetics
|
Oct 26, 2017 10:24AM
|
|
Re: Resverlogix Announces Topline Results in BETonMACE Phase 3 Epigenetics Trial
|
2
|
Resverlogix Corp.
|
Sep 30, 2019 09:57AM
|
|
Re: NR on phase 1 Kidney Trial
|
2
|
Resverlogix Corp.
|
Jan 23, 2017 02:04PM
|
|
Heads Up
|
2
|
Resverlogix Corp.
|
May 23, 2023 08:06PM
|
|
Re: What if RRR MACE is significant at 90% confidence?
|
2
|
Resverlogix Corp.
|
Apr 24, 2018 01:03PM
|
|
Re: ... removed posts????
|
2
|
Resverlogix Corp.
|
Oct 29, 2017 02:25PM
|
|
aberaterone
|
2
|
Zenith Epigenetics
|
Jun 24, 2018 01:32PM
|
|
Re: A comment about market penetration
|
2
|
Resverlogix Corp.
|
Mar 19, 2017 03:37PM
|
|
Re: Great Discussion
|
2
|
Resverlogix Corp.
|
Oct 16, 2017 05:51PM
|
|
Re: CANTOS and CIRT
|
2
|
Resverlogix Corp.
|
Nov 13, 2017 05:15PM
|
|
Re: Motley Fool - Resverlogix one of three biotechs than can "Electrify your TFSA"
|
2
|
Resverlogix Corp.
|
Jun 24, 2018 01:51PM
|
|
Re: Insider activity, grants of rights and an option exercise at 75 cents
|
2
|
Resverlogix Corp.
|
Jun 18, 2019 11:58AM
|
